Abstract
Breast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.
Publication types
-
Case Reports
-
English Abstract
-
Review
MeSH terms
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Echocardiography
-
Electrocardiography
-
Female
-
Humans
-
Pulmonary Embolism / chemically induced*
-
Pulmonary Embolism / diagnosis
-
Tamoxifen / therapeutic use*
Substances
-
Antineoplastic Agents, Hormonal
-
Tamoxifen